LHCCX Holdings — Lord Abbett Health Care Fund
Data updated: 2026-09-25
LHCCX holds 61 securities. The top 10 make up 42.9% of net assets, led by Eli Lilly & (10.40%) and UnitedHealth Group (5.39%). Health Care (97.1%) and Information Technology (1.0%) are the largest sectors, and 78.5% of the portfolio is in United States. No debt holdings are reported.
Holdings cover 100.11% of net asset value (99.23% of total assets; remainder is cash and receivables). As of July 31, 2026 · N-PORT.
LHCCX Portfolio Holdings
61 holdings of Lord Abbett Health Care Fund by percentage of net assets, from the fund's SEC N-PORT filing as of July 31, 2026.
| Holding | Ticker | Sector | % of net assets | Value (USD) |
|---|---|---|---|---|
| Eli Lilly & Co | LLY | Health Care | 10.40% | $890.35K |
| UnitedHealth Group Inc | UNH | Health Care | 5.39% | $462.06K |
| Johnson & Johnson | JNJ | Health Care | 4.96% | $424.52K |
| Novartis AG | NVSEF | Health Care | 4.19% | $358.45K |
| Natera Inc | NTRA | Health Care | 3.60% | $308.19K |
| Gilead Sciences Inc | GILD | Health Care | 3.53% | $302.48K |
| CVS Health Corp | CVS | Health Care | 3.33% | $285.51K |
| Guardant Health Inc | GH | Health Care | 2.61% | $223.71K |
| Galderma Group AG | — | Health Care | 2.60% | $222.62K |
| Thermo Fisher Scientific Inc | TMO | Health Care | 2.31% | $198.13K |
| Cogent Biosciences Inc | COGT | Health Care | 2.27% | $193.99K |
| Vertex Pharmaceuticals Inc | VRTX | Health Care | 2.24% | $191.79K |
| 10X Genomics Inc | TXG | Health Care | 2.16% | $184.83K |
| BeOne Medicines Ltd | BEIGF | Health Care | 2.06% | $176.28K |
| Ascendis Pharma A/S | ASND | Health Care | 1.99% | $170.25K |
| AstraZeneca PLC | AZN | Health Care | 1.97% | $168.75K |
| Madrigal Pharmaceuticals Inc | MDGL | Health Care | 1.91% | $163.56K |
| Bridgebio Pharma Inc | BBIO | Health Care | 1.84% | $157.70K |
| Edwards Lifesciences Corp | EW | Health Care | 1.78% | $152.77K |
| Revolution Medicines Inc | RVMD | Health Care | 1.67% | $143.27K |
| Arrowhead Pharmaceuticals Inc | ARWR | Health Care | 1.52% | $130.19K |
| Protagonist Therapeutics Inc | PTGX | Health Care | 1.44% | $123.66K |
| Dianthus Therapeutics Inc | DNTH | Health Care | 1.44% | $123.17K |
| Adaptive Biotechnologies Corp | ADPT | Health Care | 1.42% | $122.04K |
| Illumina Inc | ILMN | Health Care | 1.42% | $121.83K |
| United Therapeutics Corp | UTHR | Health Care | 1.41% | $121.14K |
| Argenx SE | — | Health Care | 1.35% | $115.63K |
| Ucb SA | — | Health Care | 1.35% | $115.51K |
| Mirum Pharmaceuticals Inc | MIRM | Health Care | 1.34% | $115.17K |
| Glaukos Corp | GKOS | Health Care | 1.31% | $111.87K |
| PTC Therapeutics Inc | PTCT | Health Care | 1.30% | $110.99K |
| Teva Pharmaceutical Industries Ltd | TEVA | Health Care | 1.21% | $103.52K |
| Fixed, Inc. Clearing Corp.repo | — | Unknown | 1.21% | $103.31K |
| Otsuka Holdings Co Ltd | — | Health Care | 1.17% | $100.40K |
| Intuitive Surgical Inc | ISRG | Health Care | 1.07% | $91.51K |
| Roivant Sciences Ltd | ROIV | Health Care | 1.06% | $90.68K |
| CG oncology Inc | CGON | Health Care | 1.02% | $87.07K |
| Hinge Health Inc | HNGE | Information Technology | 0.98% | $83.90K |
| Enliven Therapeutics Inc | ELVN | Health Care | 0.95% | $81.01K |
| Oruka Therapeutics Inc | ORKA | Health Care | 0.93% | $79.91K |
| Celcuity Inc | CELC | Health Care | 0.90% | $77.40K |
| Encompass Health Corp | EHC | Health Care | 0.88% | $75.19K |
| West Pharmaceutical Services Inc | WST | Health Care | 0.81% | $69.56K |
| Newamsterdam Pharma Co NV | NAMS | Health Care | 0.81% | $69.36K |
| Forte Biosciences Inc | FBRX | Health Care | 0.79% | $67.48K |
| Definium Therapeutics Inc | DFTX | Health Care | 0.74% | $63.50K |
| Alumis Inc | ALMS | Health Care | 0.72% | $61.67K |
| Stryker Corp | SYK | Health Care | 0.71% | $60.58K |
| Praxis Precision Medicines Inc | PRAX | Health Care | 0.69% | $59.41K |
| Fidelity Investments Money Market Government Portfolio | — | Funds & ETFs | 0.68% | $58.35K |
| Tango Therapeutics Inc | TNGX | Health Care | 0.63% | $54.36K |
| Samsung Biologics Co Ltd | — | Health Care | 0.61% | $52.47K |
| IDEXX Laboratories Inc | IDXX | Health Care | 0.58% | $49.76K |
| HeartFlow Inc | HTFL | Health Care | 0.47% | $40.42K |
| DBV Technologies SA | DBVT | Health Care | 0.47% | $40.14K |
| Scholar Rock Holding Corp | SRRK | Health Care | 0.45% | $38.88K |
| Jade Biosciences Inc | JBIO | Health Care | 0.45% | $38.20K |
| Kymera Therapeutics Inc | KYMR | Health Care | 0.44% | $37.43K |
| BrightSpring Health Services Inc | BTSG | Health Care | 0.42% | $36.12K |
| Citibank Na Ddca | — | Funds & ETFs | 0.08% | $6.48K |
| Argenx SE | — | Health Care | 0.07% | $6.01K |
LHCCX Sector Allocation
Lord Abbett Health Care Fund holdings grouped by sector, by share of the portfolio's market value.
| Sector | Weight | Holdings |
|---|---|---|
| Health Care | 97.1% | 57 |
| Information Technology | 1.0% | 1 |
| Funds & ETFs | 0.8% | 2 |
| Unknown | 1.2% | 1 |
LHCCX Country Allocation
Where Lord Abbett Health Care Fund's holdings are domiciled, by percentage of net assets (largest 12).
| Country | % of net assets |
|---|---|
| United States | 78.5% |
| Switzerland | 8.8% |
| Netherlands | 2.2% |
| Denmark | 2.0% |
| United Kingdom | 2.0% |
| Belgium | 1.4% |
| Israel | 1.2% |
| Japan | 1.2% |
| Bermuda | 1.1% |
| Canada | 0.7% |
| South Korea | 0.6% |
| France | 0.5% |
LHCCX Portfolio Allocation
Asset-class allocation of Lord Abbett Health Care Fund by percentage of net assets, from the latest SEC N-PORT filing.
| Asset class | Allocation |
|---|---|
| Equity | 98.2% |
| Cash & Equivalents | 2.0% |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.